Skip to main content
All lobbying filings

ARTEMIS POLICY GROUP LLC

Lobbying for SUSAN G. KOMEN · organization addressing breast cancer through research, community health, public policy

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 19, 2026
Income
$40,000
What the client paid this registrant for the period.
Client based in
Texas

Official filing document

 Lobbyists on this filing 2
  • JOHANNA GRAY
    Previously held: Intern, Senator Barack Obama
  • LESLIE BRADY
    Previously held: Health Policy Advisor/Legislative Assistant, Rep. Brian Higgins

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 6

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 4

FY27 appropriations for the National Breast and Cervical Cancer Early Detection Program FY27 appropriations for breast cancer research FY27 appropriations for cancer prevention and control

Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Protect patients from substandard and junk insurance products Implementation of One Big Beautiful Bill Act (H.R.1) Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions HELP Copays Act (S. 864, H.R. 6423) Excepted Fertility Benefits Proposed Rules (1210-AC40)

Medicare coverage policy for breast cancer treatments and services Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act H.R. 2048, Metastatic Breast Cancer Access to Care Act H.R.8839 - Lainie Jones Comprehensive Cancer Survivorship Act of 2026 Personalized Risk Evaluation For Effective Risk Reduction and Early Detection Screening Act (S. 5258) Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R.842/S.339) Implementation of Medicaid Community Engagement requirements, including Interim Final Rule on Medicaid Program: Community Engagement Requirement for Certain Individuals (CMS-2454-IFC) Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Federal Anti-Kickback Statute and Beneficiary Inducements CMP (OIG-2602-N) Calendar Year 2027 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Proposed Rule (CMS-1850-P)

Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies related to the availability and patient awareness of breast cancer risk assessments H.R. 4541, the EARLY Act Reauthorization of 2025 Issues related to the US Preventive Services Task Force Policies related to the impact of tariffs on the availability of silicone prosthetics National Breast Cancer Awareness Month Breast Cancer Research Stamp Reauthorization Act (H.R. 8358) Breast Cancer Stamp Reauthorization Act (S.4318) Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-GRAIL, Inc. Galleri (Docket No. FDA-2026-N-8004) Proposed Rule on Regulation for Federal Financial Assistance (OMB-2026-0034)

 Bills named in this filing 15
  • H.R. 3037
    Access to Breast Cancer Diagnosis Act of 2025
  • S. 1500
    Access to Breast Cancer Diagnosis Act of 2025
  • H.R. 1
    One Big Beautiful Bill Act
  • S. 864
    HELP Copays Act
  • H.R. 6423
    HELP Copays Act
  • H.R. 2048
    Metastatic Breast Cancer Access to Care Act
  • H.R. 8839
    Lainie Jones Comprehensive Cancer Survivorship Act of 2026
  • S. 5258
    PREFERRED Screening Act
  • H.R. 842
    Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
  • S. 339
    Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
  • H.R. 2381
    SCREENS for Cancer Act of 2025
  • S. 1866
    SCREENS for Cancer Act of 2025
  • H.R. 4541
    EARLY Act Reauthorization of 2025
  • H.R. 8358
    Breast Cancer Research Stamp Reauthorization Act of 2026
  • S. 4318
    Breast Cancer Stamp Reauthorization Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem